The ‘real’ Alzheimer’s gene steps forwardPrevention trial enrolls patients identified as high-risk for late-onset disease by genetic testing Vimpat: new antiepileptic for partial seizuresUCB Canada is introducing Vimpat as adjunctive therapy in the management of epilepsy. Peoples’ jobs linked to area of brain degeneration For physicians with a patient presenting with signs of dementia, the person’s career path may provide clues about their brain health. ‘Destination amnesia’ could impair patient encounters Facing autism A focus on diagnosis, current controversies and proven treatments. First oral MS drug approved in U.S. Fingolimod (Gilenya, Novartis) offers patients an alternative to injectable therapies. Two Canadian centres win stroke care honours Calgary, Toronto Rehab earn new accreditation Stroke costs in Canada found to be double previous estimates Price-tag for first six months after ischemic stroke: close to $50,000 Apixaban reduces AF patients’ stroke risk compared with ASA Agent tested in atrial fibrillation patients who are unsuitable for warfarin therapy Community program reduces cardiovascular hospitalization rate Teaching volunteer peer educators about risk factors and how to reduce them proves effective in Canadian study Daughters more prone to depression than sons when caring for parent with stroke Supports needed for family members who are “critical” to stroke recovery: MD Younger stroke patients show evidence of previous damage Under-50s who have had ‘silent’ strokes are at higher risk for another stroke; MRIs recommended for all young stroke patients First Previous 47 48 49 50 51 Next Last
